Lacrimal Passage Obstruction Clinical Trial
Official title:
Adult Encysted Dacryocystocele: Prevalence Among Patients With Epiphora and Its Management
Verified date | January 2020 |
Source | Minia University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Patients with lacrimal dacryocystocele were chosen for the study. Dacryocystorhinostomy were done for them after their evaluation.
Status | Completed |
Enrollment | 34 |
Est. completion date | December 30, 2019 |
Est. primary completion date | November 21, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 19 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Lacrimal sac mucocele - Acquired type Exclusion Criteria: - No previous lacrimal sac surgery - Suspected lacrimal sac malignancy |
Country | Name | City | State |
---|---|---|---|
Egypt | Faculty of Medicine | Minya | Minia |
Lead Sponsor | Collaborator |
---|---|
Minia University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Patency of the lacrimal passage | Disappearance of the watering of the eye reported by the patients and by fluorescein disappearance test | 2 weeks | |
Primary | Disappearance of lacrimal sac swelling | No evident swelling in the medial side of the eye | 1 month |